 |
| CrossRef Text and Data Mining |
| Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining. |
| Incidence of Acute Endophthalmitis after Intravitreal Antivascular Endothelial Growth Factor Injection in Age-related Macular Degeneration |
| Hyo Jin Seong, Young Min Park, Jiwon Kim, Kang Ju Son, Eun Jee Chung |
|
Korean J Ophthalmol. 2022;36(5):435-442. Published online August 19, 2022 DOI: https://doi.org/10.3341/kjo.2022.0088 |
|
Incidence of Acute Endophthalmitis after Intravitreal Antivascular Endothelial Growth Factor Injection in Age-related Macular Degeneration Korean Journal of Ophthalmology. 2022;36(5):435-442  Antivascular Endothelial Growth Factor Treatment Might Be Continued Even After Vitrectomy for Endophthalmitis in Neovascular Age-Related Macular Degeneration Journal of VitreoRetinal Diseases. 2019;4(1):6-12 Intraocular pressure changes after repeated intravitreal antivascular endothelial growth factor injections in patients with neovascular age-related macular degeneration with or without glaucoma Taiwan Journal of Ophthalmology. 2014;4(1):28-32 Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration Drug Design, Development and Therapy. 2013;485 Choroidal Thickness Changes After Intravitreal Antivascular Endothelial Growth Factor Therapy for Age-Related Macular Degeneration: Ranibizumab Versus Aflibercept Journal of Ocular Pharmacology and Therapeutics. 2015;31(6):357-362 Comment on “Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration” Eye. 2021;36(2):477-477 Response to: Comment on: Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration Eye. 2021;36(2):474-474 Incidence of Retinal Pigment Epithelial Tears after Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration Yearbook of Ophthalmology. 2012;2012:140-142 Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy . 2019; Repeated intravitreal injections of antivascular endothelial growth factor in patients with neovascular age-related macular degeneration may increase the risk of ischemic optic neuropathy . 2019; |
